Behold world! The clinical trials for CutoSense’s WoundWatch wound assessment systems have officially started! This will be the first truly disruptive innovation in wound care since the invention of the camera.
TCAF Member Finnadvance raises a €1.2 million seed funding round to expand to foreign markets. For more information, please read the press release here.
EpiHeart raised more than 200 % of the equity funding target in the funding campaign organised on the Invesdor platform.
